Please assess the completion status of the following clinical trial:

Trial Title: Ezetimibe and Atorvastatin vs. Atorvastatin in Patients Age 65 and Older at High Risk for Coronary Heart Disease (CHD)(0653-112)

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patient is age 65 or older~* Patient is willing to maintain cholesterol lowering diet~* Patient has hyperlipidemia with LDL level greater than 70 mg/dl or 100 mg/dl depending on their CHD risk category~Exclusion Criteria:~* A condition which, in the opinion of the investigator, would pose a risk to the patient or interfere with participation in the study~* Patient is unlikely to be compliant in taking study medication~* Patient with chronic or unstable medical condition~* Patient is taking unstable doses of medication~* Patient drinks more than 2 alcoholic drinks per day~* Patient has elevations in certain laboratory values (CK, AST, ALT)

- Gender: ALL
- Minimum Age: 65 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: ACTIVE_COMPARATOR): None
- 2 (Type: ACTIVE_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).